BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17057204)

  • 1. Inflammatory bowel disease and the apical junctional complex.
    Bruewer M; Samarin S; Nusrat A
    Ann N Y Acad Sci; 2006 Aug; 1072():242-52. PubMed ID: 17057204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the intestinal epithelial barrier by the apical junctional complex.
    Laukoetter MG; Bruewer M; Nusrat A
    Curr Opin Gastroenterol; 2006 Mar; 22(2):85-9. PubMed ID: 16462161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.
    Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Clin Immunol; 2008 Jan; 126(1):67-80. PubMed ID: 17964857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption.
    Ivanov AI; Nusrat A; Parkos CA
    Novartis Found Symp; 2004; 263():115-24; discussion 124-32, 211-8. PubMed ID: 15669638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms.
    Bruewer M; Luegering A; Kucharzik T; Parkos CA; Madara JL; Hopkins AM; Nusrat A
    J Immunol; 2003 Dec; 171(11):6164-72. PubMed ID: 14634132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight junctions and cell-cell interactions.
    Utech M; Brüwer M; Nusrat A
    Methods Mol Biol; 2006; 341():185-95. PubMed ID: 16799199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of interferon-gamma-triggered internalization of tight-junction proteins in inflammatory bowel disease.
    Chiba H; Kojima T; Osanai M; Sawada N
    Sci STKE; 2006 Jan; 2006(316):pe1. PubMed ID: 16391178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function.
    Oshima T; Laroux FS; Coe LL; Morise Z; Kawachi S; Bauer P; Grisham MB; Specian RD; Carter P; Jennings S; Granger DN; Joh T; Alexander JS
    Microvasc Res; 2001 Jan; 61(1):130-43. PubMed ID: 11162203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition.
    Willemsen LE; Hoetjes JP; van Deventer SJ; van Tol EA
    Clin Exp Immunol; 2005 Nov; 142(2):275-84. PubMed ID: 16232214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosis and recycling of tight junction proteins in inflammation.
    Utech M; Mennigen R; Bruewer M
    J Biomed Biotechnol; 2010; 2010():484987. PubMed ID: 20011071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.
    Amasheh M; Grotjohann I; Amasheh S; Fromm A; Söderholm JD; Zeitz M; Fromm M; Schulzke JD
    Scand J Gastroenterol; 2009; 44(10):1226-35. PubMed ID: 19658020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with alpha-catenin: implications for inflammatory bowel diseases.
    Orsó E; Moehle C; Boettcher A; Szakszon K; Werner T; Langmann T; Liebisch G; Buechler C; Ritter M; Kronenberg F; Dieplinger H; Bornstein SR; Stremmel W; Schmitz G
    Horm Metab Res; 2007 Aug; 39(8):601-11. PubMed ID: 17712726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers.
    Ivanov AI; Nusrat A; Parkos CA
    Bioessays; 2005 Apr; 27(4):356-65. PubMed ID: 15770686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α-induced intestinal epithelial cell shedding: implications for intestinal barrier function.
    Watson AJ; Hughes KR
    Ann N Y Acad Sci; 2012 Jul; 1258():1-8. PubMed ID: 22731709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
    Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines.
    Li Q; Zhang Q; Wang M; Zhao S; Xu G; Li J
    Mol Immunol; 2008 Mar; 45(5):1356-65. PubMed ID: 17936906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases.
    Francoeur C; Bouatrouss Y; Seltana A; Pinchuk IV; Vachon PH; Powell DW; Sawan B; Seidman EG; Beaulieu JF
    Gastroenterology; 2009 Jan; 136(1):268-277.e3. PubMed ID: 18976656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.